Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Post by threefiftynineon Jun 11, 2020 7:35am
95 Views
Post# 31137428

-------------GREED-------

-------------GREED-------
Its a worldwide problem we all know that --"-money makes the world go round ". as they say. Now as VH and bligicka have stated something happened at .17 cents after the announcement that Vaxil would be accepted in to the SOURASKY MED CENTRE . see news dated May 5th. Now that's the same day they announced 2 important factors. #1--"Tel Aviv Medical Center -- to advance the Companys research program to develop a potential peptide vaccine against COVID-19." #2---"The Company does not anticipate the need to raise additional funds to finance this work"...... What happened in this time period to all of a sudden cause a major decrease in the stock value when in essence it should have reached new highs ????---yes 4 question marks.---!-----My opinion is MPartners were contacted with information regarding testing and or funding and private placement was brought in to the mix----now bare in mind we are trading at .17 cents at this time. FAST FORWARD 21 days and a PP is pressed at .085 with obviously dilution a major concern after the 4 month hold expires. ---We will know the answer shortly to this puzzle when the participants are announced on SEDI and yes im watching SEDI like a hawk norman.---If the rumours going around that it is over subscribed and insiders including the broker are invoved then we will have the answer and the answer may well be quite simple -----GREED. ---
<< Previous
Bullboard Posts
Next >>